Streptococcus A Rapid Diagnostic Testing in England Community Pharmacies: Clinical and Economic Impact of Empowering Pharmacists in Management of Sore Throat
Journal of Primary Care & Community Health · 2025
DOI: 10.1177/21501319251340836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Primary Care & Community Health, 2025. Verfasst von Kay Edokpayi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Reckitt Health, Slough, UK. Hauptthemen laut MEDLINE: Pharyngitis, Streptococcal Infections, Pharmacists, Streptococcus pyogenes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Reckitt Benckiser Pharmaceuticals.
Abstract (Originalsprache)
Introduction
Many patients with sore throat receive antibiotics from their general practitioners (GPs); however, only a minority are affected by bacterial infection, often streptococcal A (Strep A). Rapid diagnostic test can improve diagnosis, guide treatment decisions and direct patients when required for appropriate self-care. This study investigates the potential benefit of Strep A rapid tests in pharmacies for sore throat patients, with the aim of maximising healthcare resources.
Methods
Participants over 16 years old were screened using FeverPAIN scores, and those with high scores were tested for Strep A. To estimate avoided GP visits, participants completed a questionnaire on treatment choice (Accident & Emergency (A&E) GP visit, pharmacist, self-care) if the diagnostic service was unavailable. Results and Conclusion: Majority (86%) tested negative. The questionnaire revealed that 67% could avoid GP visits. When extrapolated to the UK, this could result in an estimated annual saving of £263 million for the National Health Service (NHS) Despite not being recommended for routine use by NICE, the study suggests that such rapid diagnostic testing for Strep A, combined with FeverPAIN screening, could prevent antimicrobial misuse, alleviate NHS pressure and empower pharmacists. This is particularly relevant considering the recent implementation of the pharmacy-first service.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reckitt Health, Slough, UK.
- Respiratory Pharmacist Northwest London, UK.
ORCID-Profile: Patricia Aluko
Förderung
- Reckitt Benckiser Pharmaceuticals
Zitieren
APA
Edokpayi, K., Aluko, P., Cheng, F. K. K., Attar-Zadeh, D., & Dawson, A. (2025). Streptococcus A Rapid Diagnostic Testing in England Community Pharmacies: Clinical and Economic Impact of Empowering Pharmacists in Management of Sore Throat. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319251340836
Vancouver
Edokpayi K, Aluko P, Cheng FKK, Attar-Zadeh D, Dawson A. Streptococcus A Rapid Diagnostic Testing in England Community Pharmacies: Clinical and Economic Impact of Empowering Pharmacists in Management of Sore Throat. Journal of Primary Care & Community Health. 2025. doi:10.1177/21501319251340836
BibTeX
@article{Edokpayi2025,
author = {Edokpayi, Kay and Aluko, Patricia and Cheng, Flora Ka Kei and Attar-Zadeh, Darush and Dawson, Anne},
title = {Streptococcus A Rapid Diagnostic Testing in England Community Pharmacies: Clinical and Economic Impact of Empowering Pharmacists in Management of Sore Throat},
journal = {Journal of Primary Care & Community Health},
year = {2025},
doi = {10.1177/21501319251340836}
}
EUVIMED